Related Experiment Video

Updated: Jul 10, 2025

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
09:37

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

15.1K

[Hemodynamic Changes in Chronic Liver Disease]

Sangyong Jo1,2, Kyungil Park1,2

  • 1Division of Cardiology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.

The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi
|November 24, 2023
PubMed

Insights

Chronic liver disease leads to harmful hemodynamic changes, including splanchnic vasodilation and hyperdynamic circulation. These changes worsen portal hypertension and complications like ascites, decreasing blood pressure in advanced stages.

Area of Science:

  • Cardiovascular Physiology
  • Hepatology

Context:

  • Chronic liver disease (CLD) significantly alters systemic hemodynamics.
  • Progression of CLD is associated with developing splanchnic vasodilation and hyperdynamic circulatory state.

Purpose:

  • To elucidate the hemodynamic alterations in chronic liver disease.
  • To correlate these changes with disease progression and complications.

Summary:

  • Hemodynamic changes in CLD initiate with splanchnic vasodilation and hyperdynamic circulation.
  • Worsening vasodilation and hyperdynamic state exacerbate portal hypertension.
  • Advanced CLD stages are characterized by decreased effective plasma volume and arterial pressure.

Impact:

  • Understanding these hemodynamic shifts is crucial for managing CLD complications.
  • Provides insights into the pathophysiology of ascites and other sequelae.
  • Highlights the terminal hemodynamic profile in end-stage liver disease.

Keywords:
HemodynamicsLiver diseasesSplanchnic circulation

More Related Videos

Monitoring of Systemic and Hepatic Hemodynamic Parameters in Mice16:09

Monitoring of Systemic and Hepatic Hemodynamic Parameters in Mice

Published on: October 4, 2014

16.2K
Visualization and Analysis of Blood Flow and Oxygen Consumption in Hepatic Microcirculation: Application to an Acute Hepatitis Model10:40

Visualization and Analysis of Blood Flow and Oxygen Consumption in Hepatic Microcirculation: Application to an Acute Hepatitis Model

Published on: August 4, 2012

12.7K

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
72
Liver Physiology01:30

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
575
Hepatic Drug Clearance: Effect of Protein Binding01:09

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
210